Latest Tax Refunds News

Tissue Repair advances its US Phase III chronic wound trial with 100 patients randomised and targets October FDA 510(k) submission. The company reports a robust cash position bolstered by R&D refunds and has cut manufacturing scale-up costs.

Alterity Therapeutics has cleared a major regulatory hurdle with the FDA endorsing a single pivotal Phase 3 trial for its ATH434 drug in Multiple System Atrophy, setting the stage for trial initiation by the end of 2026.

Miramar Resources has doubled its gold Exploration Target at the Gidji JV near Kalgoorlie and completed its first drilling program at Chain Pool in over 60 years, while finalising the sale of Randalls Project and securing government grants to fund ongoing exploration.

PainChek lifted implemented ARR by 5.9% to $4.46 million and secured its first US commercial contracts under a major Sabra REIT agreement, boosting customer receipts 27% in the June quarter.

Iluka Resources reported a rebound in zircon sales and prices in Q2 2026, while advancing its Eneabba rare earths refinery to nearly 60% completion and securing a key rare earths offtake deal.

Australian Gold and Copper Ltd (ASX: AGC) has completed the second tranche of its $5 million placement, received a nearly $1 million R&D tax refund, and finalized the acquisition of the drill-ready Junee gold project in NSW.

PainChek has received a $1.123 million R&D tax incentive refund for FY2025, reinforcing its cash reserves and underpinning ongoing development of AI pain assessment algorithms and US market validation.

Paradigm Biopharmaceuticals has strengthened its balance sheet with a combined $5.75 million cash inflow from Australian Government R&D tax incentives, supporting its pivotal Phase 3 osteoarthritis trial and regulatory efforts.

Recce Pharmaceuticals secured a non-binding term sheet with a major Middle Eastern pharma for its diabetic foot infection treatment and raised A$4 million to fund pivotal Phase 3 trials in Australia and Indonesia.

Miramar Resources has received a A$238,456 refundable R&D tax offset for FY2025, supporting innovative exploration techniques at its Whaleshark and Bangemall projects. This non-dilutive funding strengthens the company’s cash position ahead of planned drilling and surveys.

Karoon Energy reveals the Brazilian government has extended its 12% crude oil export tax for an additional 60 days. The company continues legal efforts to contest the tax while leveraging trade agreements to mitigate its impact.

Venari Metals has agreed to sell its Georgina Basin IOCG Project in the Northern Territory to UK-listed Alien Minerals, marking a strategic shift towards its lithium and critical metals operations in Nevada. The deal includes cash, equity, and a technical services agreement, but will trigger a significant accounting loss.